Evidence map›Paper›PMID 26459550›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2015

False-positive Xpert(®) MTB/RIF more than seven years after cure.

D R Stevenson, J R Biswas, A Lievesley, G Quinn, J Buckley, L John, R N Davidson

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Sputum smear microscopy in the XpertThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019
    Article
  6. Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

D R StevensonDepartment of Infectious Diseases, Northwick Park Hospital, London, UK. danny.r.stevenson@gmail.com.
J R BiswasDepartment of Infectious Diseases, Northwick Park Hospital, London, UK.
A LievesleyDepartment of Infectious Diseases, Northwick Park Hospital, London, UK.
G QuinnDepartment of Infectious Diseases, Northwick Park Hospital, London, UK.
J BuckleyDepartment of Infectious Diseases, Northwick Park Hospital, London, UK.
L JohnDepartment of Infectious Diseases, Northwick Park Hospital, London, UK.
R N DavidsonDepartment of Infectious Diseases, Northwick Park Hospital, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, BacterialAntibiotics, AntitubercularFemaleHumansMycobacterium tuberculosisNucleic Acid Amplification TechniquesRespiratory Tract InfectionsRifampinTuberculosisTuberculosis, PulmonaryAntibiotics, AntitubercularRifampin

Identifiers

PMID26459550

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.